Claudia Grimaldi is a Vice President and Director, where she oversees international teams across preclinical research, regulatory compliance, and trial operations. She plays a key role in managing IGC’s FDA-registered Alzheimer’s trials. Claudia brings a unique blend of psychological insight and operational rigor to her leadership. Her work builds critical bridges between scientists, clinicians, and advisors worldwide. She holds an MBA and has extensive experience in healthcare management.